Bdh Industries [BDH] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Bdh Industries Ltd. wins in 9 metrics, Divi's Laboratories Ltd. wins in 11 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Bdh Industries Ltd. | Divi's Laboratories Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 21.06 | 67.11 | Bdh Industries Ltd. |
| Price-to-Book Ratio | 3.11 | 10.82 | Bdh Industries Ltd. |
| Debt-to-Equity Ratio | 0.04 | 0.58 | Bdh Industries Ltd. |
| PEG Ratio | 0.87 | 4.63 | Bdh Industries Ltd. |
| EV/EBITDA | 14.26 | 48.63 | Bdh Industries Ltd. |
| Profit Margin (TTM) | 12.30% | 24.04% | Divi's Laboratories Ltd. |
| Operating Margin (TTM) | 13.67% | 29.65% | Divi's Laboratories Ltd. |
| EBITDA Margin (TTM) | 13.67% | 29.65% | Divi's Laboratories Ltd. |
| Return on Equity | 13.49% | 14.64% | Divi's Laboratories Ltd. |
| Return on Assets (TTM) | 10.67% | 12.94% | Divi's Laboratories Ltd. |
| Free Cash Flow (TTM) | $145.56M | $2.15B | Divi's Laboratories Ltd. |
| Dividend Yield | 2.98% | 0.91% | Bdh Industries Ltd. |
| 1-Year Return | 52.71% | -0.43% | Bdh Industries Ltd. |
| Price-to-Sales Ratio (TTM) | 2.59 | 16.18 | Bdh Industries Ltd. |
| Enterprise Value | $1.86B | $1,635.46B | Divi's Laboratories Ltd. |
| EV/Revenue Ratio | 2.19 | 15.86 | Bdh Industries Ltd. |
| Gross Profit Margin (TTM) | 24.77% | 63.71% | Divi's Laboratories Ltd. |
| Revenue per Share (TTM) | $147 | $388 | Divi's Laboratories Ltd. |
| Earnings per Share (Diluted) | $18.09 | $93.66 | Divi's Laboratories Ltd. |
| Beta (Stock Volatility) | 0.21 | 0.19 | Divi's Laboratories Ltd. |
Bdh Industries Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Bdh Industries Ltd. | 12.41% | 25.64% | 21.89% | 7.78% | 14.73% | 7.65% |
| Divi's Laboratories Ltd. | -0.44% | 1.34% | -2.25% | 8.85% | 4.11% | 4.17% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Bdh Industries Ltd. | 52.71% | 153.63% | 269.02% | 364.46% | 2,121.21% | 3,639.80% |
| Divi's Laboratories Ltd. | -0.43% | 85.44% | 58.15% | 496.33% | 1,610.60% | 10,946.76% |
Performance & Financial Health Analysis: Bdh Industries Ltd. vs Divi's Laboratories Ltd.
| Metric | BDH | DIVISLAB |
|---|---|---|
| Market Information | ||
| Market Cap | ₹2.16B | ₹1.69T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 668 | 253,443 |
| 90 Day Avg. Volume | 1,731 | 283,911 |
| Last Close | ₹453.20 | ₹6,608.50 |
| 52 Week Range | ₹257.05 - ₹523.75 | ₹5,636.50 - ₹7,071.50 |
| % from 52W High | -13.47% | -6.55% |
| All-Time High | ₹523.75 (Oct 06, 2025) | ₹7,071.50 (Jul 08, 2025) |
| % from All-Time High | -13.47% | -6.55% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.81% | 0.12% |
| Quarterly Earnings Growth | 0.24% | -0.01% |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | 0.24% |
| Operating Margin (TTM) | 0.14% | 0.30% |
| Return on Equity (TTM) | 0.13% | 0.15% |
| Debt to Equity (MRQ) | 0.04 | 0.58 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹122.68 | ₹580.95 |
| Cash per Share (MRQ) | ₹62.75 | ₹122.95 |
| Operating Cash Flow (TTM) | ₹227.86M | ₹19.67B |
| Levered Free Cash Flow (TTM) | ₹92.73M | ₹21.91B |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.98% | 0.91% |
| Last 12-Month Dividend | ₹9.00 | ₹60.00 |
Valuation & Enterprise Metrics Analysis: Bdh Industries Ltd. vs Divi's Laboratories Ltd.
| Metric | BDH (Apr 24, 2026) | DIVISLAB (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 21.06 | 67.11 |
| Forward P/E | 52.92 | 53.75 |
| PEG Ratio | 0.87 | 4.63 |
| Price to Sales (TTM) | 2.59 | 16.18 |
| Price to Book (MRQ) | 3.11 | 10.82 |
| Market Capitalization | ||
| Market Capitalization | ₹2.16B | ₹1.69T |
| Enterprise Value | ₹1.86B | ₹1.64T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.19 | 15.86 |
| Enterprise to EBITDA | 14.26 | 48.63 |
| Risk & Other Metrics | ||
| Beta | 0.21 | 0.19 |
| Book Value per Share (MRQ) | ₹122.68 | ₹580.95 |
Financial Statements Comparison: Bdh Industries Ltd. vs Divi's Laboratories Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | BDH (2025) | DIVISLAB (2025) |
|---|---|---|
| Revenue/Sales | 648.86M | 93.25B |
| Cost of Goods Sold | 413.98M | 38.70B |
| COGS % of Revenue | 63.8% | 41.5% |
| Gross Profit | 234.88M | 54.55B |
| Gross Margin | 36.2% | 58.5% |
| Research & Development | 2.33M | 270.00M |
| Operating Income (EBIT) | 107.01M | 25.71B |
| Operating Margin | 16.5% | 27.6% |
| EBITDA | 134.45M | 33.19B |
| EBITDA Margin | 20.7% | 35.6% |
| Pre-Tax Income | 124.67M | 29.16B |
| Pre-Tax Income % of Revenue | 19.2% | 31.3% |
| Income Tax | 31.94M | 7.25B |
| Income Tax % of Revenue | 4.9% | 7.8% |
| Net Income (Profit) | 92.73M | 21.91B |
| Profit Margin | 14.3% | 23.5% |
Balance Sheet & Liquidity Metrics
| Metric | BDH (2025) | DIVISLAB (2025) |
|---|---|---|
| Cash & Equivalents | 307.12M | 4.15B |
| Total Current Assets | 667.49M | 100.81B |
| Total Current Assets % of Revenue | 102.9% | 108.1% |
| Total Current Liabilities | 169.17M | 14.52B |
| Total Current Liabilities % of Revenue | 26.1% | 15.6% |
| Long-Term Debt | N/A | 20.00M |
| Long-Term Debt % of Revenue | 0.0% | 0.0% |
| Total Shareholders Equity | 687.62M | 149.69B |
| Retained Earnings | 457.59M | 134.00B |
| Retained Earnings % of Revenue | 70.5% | 143.7% |
| Property, Plant & Equipment | 146.88M | 3.19B |
Cash Flow Statement Comparison
| Metric | BDH (2025) | DIVISLAB (2025) |
|---|---|---|
| Operating Cash Flow | 227.86M | 19.67B |
| Operating Cash Flow % of Revenue | 35.1% | 21.1% |
| Capital Expenditures | -2.15M | -14.38B |
| Free Cash Flow | 145.56M | 2.15B |
| FCF Margin | 22.4% | 2.3% |
| Debt Repayment | -77.11M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BDH | DIVISLAB |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 5.76M | 265.47M |
| Float Shares | 2.26M | 117.72M |
| % Held by Insiders | 57.26% | 52.04% |
| % Held by Institutions | 0.00% | 28.65% |
| % Held by Public | 42.74% | 19.31% |
Dividend Analysis & Yield Comparison: Bdh Industries Ltd. vs Divi's Laboratories Ltd.
| Metric | BDH | DIVISLAB |
|---|---|---|
| Last 12-Month Dividend | ₹9.00 | ₹60.00 |
| Last 12-Month Dividend Yield | 2.98% | 0.91% |
| 3-Year Avg Annual Dividend | ₹5.53 | ₹50.00 |
| 3-Year Avg Dividend Yield | 1.92% | 0.70% |
| 3-Year Total Dividends | ₹16.60 | ₹150.00 |
| Ex-Dividend Date | Aug 01, 2025 | Jul 25, 2025 |